Monkeypox antiviral drug put to the test in trial

by | Aug 23, 2022 | Health

Tecovirimat – also known as Tpoxx – prevents the virus from leaving infected cells, stopping its spread within the body. It was licensed earlier this year for monkeypox, based on promising results from initial studies in animals and evidence of safety in healthy human volunteers.

Article Attribution | Read More at Article Source

Share This